Hypermutable bacteria of several species have been described among isolates recovered from humans over the last decade. Interpretation of the literature in this area is complicated by diversity in the determination and definition of hypermutability, and this review outlines the different methods used. Inactivation of the mismatch repair gene mutS is often implicated in the mutator phenotype; the reported effect of mutS inactivation on mutation frequency varies widely between species, from under 10-fold to nearly 1000-fold, but also varies among different reports on the same species. Particularly high proportions of mutators have been reported among Pseudomonas aeruginosa and other species in the cystic fibrosis lung, epidemic serogroup A Neisseria meningitidis, and Helicobacter pylori. Aspects of the biology of these infections that could be relevant to hypermutability are discussed, and some future directions that may increase our understanding of mutators among bacteria isolated from humans are considered.
BjorkholmB, SjolundM, FalkP. G, BergO. G, EngstrandL, AnderssonD. I.
2001; Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori . Proc Natl Acad Sci U S A 98:14607–14612[CrossRef]
BlazquezJ, OliverA, Gomez-GomezJ. M.
2002; Mutation and evolution of antibiotic resistance: antibiotics as promoters of antibiotic resistance?. Curr Drug Targets 3:345–349[CrossRef]
BucciC, LavitolaA, SalvatoreP, Del GiudiceL, MassardoD. R, BruniC. B, AlifanoP.
1999; Hypermutation in pathogenic bacteria: frequent phase variation in meningococci is a phenotypic trait of a specialized mutator biotype. Mol Cell 3:435–445[CrossRef]
CiofuO, RiisB, PresslerT, PoulsenH. E, HoibyN.
2005; Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 49:2276–2282[CrossRef]
CraneG. J, ThomasS. M, JonesM. E.
1996; A modified Luria-Delbruck fluctuation assay for estimating and comparing mutation rates. Mutat Res 354:171–182[CrossRef]
DavidsenT, BjorasM, SeebergE. C, TonjumT.
2005; Antimutator role of DNA glycosylase MutY in pathogenic Neisseria species. J Bacteriol 187:2801–2809[CrossRef]
del CampoR,
MorosiniM. I, FenollA, Munoz-AlmagroC, MaizL, BaqueroF, CantonR,
de la PedrosaE. G. 2005; Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. J Clin Microbiol 43:2207–2214[CrossRef]
DenamurE, BonacorsiS, GiraudA. 8 other authors2002; High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J Bacteriol 184:605–609[CrossRef]
GaribyanL, HuangT, KimM. 8 other authors2003; Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair 2:593–608[CrossRef]
GillespieS. H, BasuS, DickensA. L, O'SullivanD. M, McHughT. D.
2005; Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. J Antimicrob Chemother 56:344–348[CrossRef]
GiraudA, MaticI, TenaillonO, ClaraA, RadmanM, FonsM, TaddeiF.
2001; Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 291:2606–2608[CrossRef]
GutierrezO, JuanC, PerezJ. L, OliverA.
2004; Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients. Antimicrob Agents Chemother 48:3573–3575[CrossRef]
Henderson-BeggS. K, LivermoreD. M, HallL. M.
2006; Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae . J Antimicrob Chemother 57:849–854[CrossRef]
LeClercJ. E, LiB, PayneW. L, CebulaT. A.
1996; High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274:1208–1211[CrossRef]
LiB, TsuiH. C, LeClercJ. E, DeyM, WinklerM. E, CebulaT. A.
2003; Molecular analysis of mutS expression and mutation in natural isolates of pathogenic Escherichia coli . Microbiology 149:1323–1331[CrossRef]
MartinP, SunL, HoodD. W, MoxonE. R.
2004; Involvement of genes of genome maintenance in the regulation of phase variation frequencies in Neisseria meningitidis . Microbiology 150:3001–3012[CrossRef]
MillerK, O'NeillA. J, ChopraI.
2002; Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. J Antimicrob Chemother 49:925–934[CrossRef]
MorosiniM. I, BaqueroM. R, Sanchez-RomeroJ. M, NegriM. C, GalanJ. C, Perez-DiazJ. C, BaqueroF,
del CampoR. 2003; Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. Antimicrob Agents Chemother 47:1464–1467[CrossRef]
Notley-McRobbL, PintoR, SeetoS, FerenciT.
2002a; Regulation of mutY and nature of mutator mutations in Escherichia coli populations under nutrient limitation. J Bacteriol 184:739–745[CrossRef]
OliverA, CantonR, CampoP, BaqueroF, BlazquezJ.
2000; High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251–1254[CrossRef]
O'NeillA. J, ChopraI.
2002; Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low. J Antimicrob Chemother 50:161–169[CrossRef]
PangP. P, LundbergA. S, WalkerG. C.
1985; Identification and characterization of the mutL and mutS gene products of Salmonella typhimurium LT2. J Bacteriol 163:1007–1015
PrunierA. L, LeclercqR.
2005; Role of mutS and mutL genes in hypermutability and recombination in Staphylococcus aureus . J Bacteriol 187:3455–3464[CrossRef]
PrunierA. L, MalbrunyB, LauransM, BrouardJ, DuhamelJ. F, LeclercqR.
2003; High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis 187:1709–1716[CrossRef]
RichardsonA. R, StojiljkovicI.
2001; Mismatch repair and the regulation of phase variation in Neisseria meningitidis . Mol Microbiol 40:645–655[CrossRef]
RichardsonA. R, YuZ, PopovicT, StojiljkovicI.
2002; Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci U S A 99:6103–6107[CrossRef]
SamrakandiM. M, PastaF.
2000; Hyperrecombination in Streptococcus pneumoniae depends on an atypical mutY homologue. J Bacteriol 182:3353–3360[CrossRef]
ShaverA. C, DombrowskiP. G, SweeneyJ. Y, TreisT, ZappalaR. M, SniegowskiP. D.
2002; Fitness evolution and the rise of mutator alleles in experimental Escherichia coli populations. Genetics 162:557–566
TatusovR. L, FedorovaN. D, JacksonJ. D. 14 other authors2003; The COG database: an updated version includes eukaryotes. BMC Bioinformatics 4:41[CrossRef]
ThomasS. R, RayA, HodsonM. E, PittT. L.
2000; Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 55:795–797[CrossRef]
WatsonM. E., Jr,
BurnsJ. L, SmithA. L.
2004; Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. Microbiology 150:2947–2958[CrossRef]
ZhaoJ, WinklerM. E.
2000; Reduction of GC→TA transversion mutation by overexpression of MutS in Escherichia coli K-12. J Bacteriol 182:5025–5028[CrossRef]